Skip to main content
Engagement one

We run the design

For a programme that needs a defensible formulation strategy now. You send a primary sequence and a set of product targets; we return the ranked candidates and the bench plan to confirm them.

Best when the question is one molecule, and the answer is needed this quarter.

Engagement one

Accelerated Formulation Design

  • The full agent system runs on your molecule, operated by our scientists
  • A primary sequence and product targets are the whole intake
  • A scored candidate space, ranked into a priority, contingency and exploratory set
  • A statistically designed DoE plan and the SOPs to execute it
  • Typically two weeks from complete intake to the package
  • Every outcome vests in you; your materials are destroyed at close-out
Deliverables

What lands on your bench, and in your filing.

One structured, statistically coherent dataset — not a series of disconnected screening reports.

Rank-ordered formulation candidates

Fully specified — every excipient, concentration and pH stated — and ordered so the bench knows what to make first.

Confidence for every candidate

Each candidate carries its own confidence, so prioritisation is a stated judgement rather than an implicit one.

Bench-level SOPs

The standard operating procedures needed to make the candidates, written for the people who will run them.

A deliberately defined design space

One structured, statistically coherent dataset instead of a series of disconnected screening reports — which is what later comparability, scale-up and lifecycle changes rest on.

How it works

From sequence to a short list worth making.

The design space is explored computationally first. The bench is used to confirm.

Inputs

A primary sequence and a set of product targets — concentration, presentation, device, and the constraints the program already carries. Nothing more is required to start.

Computational exploration

The design space — buffer and pH, sugars and polyols, amino acid excipients, ionic strength, surfactant, chelators and antioxidants — is explored computationally rather than sampled sparsely at the bench.

Ranked candidates

A rank-ordered, fully specified set of formulation candidates, with confidence attached to each, delivered as one structured and statistically coherent dataset.

Bench confirmation

Bench-level standard operating procedures for making each candidate, so the laboratory runs a focused confirmatory exercise instead of an open-ended search.

The service

What a partner actually receives.

Starting from nothing more than a primary sequence and a set of product targets, Uplizd delivers a rank-ordered, fully specified set of formulation candidates, and the bench-level standard operating procedures needed to make them — typically within two weeks.

The usual path

An open-ended empirical search

  • Two to three development quarters, or longer
  • Grams of precious drug substance consumed
  • A broad, unguided screening matrix
  • A series of disconnected screening reports
With Uplizd

A focused confirmatory exercise

  • A ranked strategy typically within two weeks
  • Material spent confirming, not searching
  • A prioritized set of conditions
  • One structured, statistically coherent dataset

For Uplizd’s partners, this converts formulation development from an open-ended empirical search into a focused confirmatory exercise.

Business impact

The benefit shows up in three places.

Speed, cost, and the quality of the knowledge your programme carries forward.

Speed

Weeks rather than quarters.

A defensible, ranked formulation strategy is available in weeks rather than quarters, which pulls in the timing of tox lots, stability starts, first-in-human enabling material, and eventually CMC sections of regulatory filings.

  • Tox lots scheduled earlier
  • Stability starts brought forward
  • First-in-human enabling material unblocked
  • CMC sections written against a defined design space

Cost

A prioritized set, not a broad matrix.

Screening effort is concentrated on a prioritized set of conditions instead of a broad, unguided matrix. This reduces FTE time, analytical load, and the quantity of purified drug substance consumed — usually the scarcest and most expensive input at early stage.

  • Less FTE time at the bench
  • Lower analytical load
  • Less purified drug substance consumed
  • Effort spent confirming, not searching

Efficiency and knowledge quality

One coherent dataset, not scattered reports.

The partner receives a single, structured, statistically coherent dataset with confidence for every candidate, rather than a series of disconnected screening reports. The design space is defined deliberately, which strengthens later comparability, scale-up and lifecycle changes.

  • Confidence attached to every candidate
  • One structured dataset, not scattered reports
  • A deliberately defined design space
  • Stronger comparability, scale-up and lifecycle changes

Put the specialists on your molecule.

Engagements begin with a conversation and a signed agreement; access credentials follow. Send a primary sequence and your product targets, or tell us what you want built, and we will reply from a person.